ANNX CIK: 1528115

Annexon, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−131
FY22:
−146
FY23:
−144
FY24:
−154
FY25:
−216
(positive)
Change from FY21 to FY25
millions USD
FY21:
−129
FY22:
−143
FY23:
−142
FY24:
−151
FY25:
−214
(positive)
Change from FY21 to FY25
millions USD
FY21:
130
FY22:
142
FY23:
134
FY24:
−138
FY25:
−207
(positive)
Change from FY21 to FY25
millions USD
FY21:
−130
FY22:
−142
FY23:
−134
FY24:
−138
FY25:
−207

All amounts in millions USD Data sources:SEC EDGARTwelve Data